Vintage Coffee and Beverages (538920) Q4 17/18 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 17/18 earnings summary
28 Oct, 2026Executive summary
FY2017-18 total income was ₹3.15m and profit after tax was ₹12,942, down from ₹8.23m and ₹74,277, respectively, in FY2016-17.
Operations were described as modest amid challenging economic conditions; management expected business to perform well and planned future diversification.
Financial highlights
Total income was ₹3,150,620 vs ₹8,225,714 in FY2016-17; total expenses were ₹3,124,471 vs ₹8,121,643.
Profit before tax was ₹26,149 vs ₹104,071; tax expense was ₹13,207 vs ₹29,794; profit after tax was ₹12,942 vs ₹74,277.
Revenue from sales and other operating income was ₹3,150,620 vs ₹8,225,714; cost of products was ₹2,400,000 vs ₹7,294,640.
No dividend was recommended; profits were to be retained to strengthen reserves and support business growth.
Outlook and guidance
Directors expected business to perform well in the forthcoming year and said future diversification was planned.
Management cited prospective government reforms and easing investment conditions as potential support for the Indian economy and industry sentiment.
Latest events from Vintage Coffee and Beverages
- Volume-led growth, positive cash flow and freeze-dried expansion drive momentum.538920
Q2 26/27 - FY14 returned to profit, as board renewal advanced a revival plan amid suspended share trading.538920
Q4 13/14 - FY13 loss widened as accumulated losses exceeded net worth and funding needs remained substantial.538920
Q4 12/13 - No operating income, continued losses and material audit uncertainty marked FY2011/12.538920
Q4 11/12 - Revenue and earnings fell sharply; future growth plans face macro and going-concern risks.538920
Q4 14/15 - A control-changing share swap shifted the business toward coffee and chicory exports.538920
Q4 20/21 - FY16 PAT dropped to ₹494; no dividend, with diversification planned.538920
Q4 15/16 - FY17 income rose to ₹8.23m; management retained profits and eyed diversification.538920
Q4 16/17 - FY19 revenue contracted sharply, but PAT rose as management pursued rehabilitation options.538920
Q4 18/19